Which cognitive domains are improved by treatment with vortioxetine?

International Journal of Neuropsychopharmacology

Volumn 19, Issue 10, 2016, Pages 1-6

  Harrison, John E ^a,b   Lophaven, Søren ^c   Olsen, Christina K ^c  

^a METIS COGNITION LTD   (United Kingdom)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c H LUNDBECK A S   (Denmark)

Author keywords

Cognitive domains; Composite Z score; Depression; Vortioxetine

Indexed keywords

PLACEBO; VORTIOXETINE;

ADULT; AGED; ARTICLE; ATTENTION; CLINICAL EFFECTIVENESS; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEPRESSION; DIGIT SYMBOL SUBSTITUTION TEST; DOUBLE BLIND PROCEDURE; EXECUTIVE FUNCTION; HUMAN; MAJOR CLINICAL STUDY; MEMORY; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RESPONSE TIME; REY AUDITORY VERBAL LEARNING TEST; SIMPLE REACTION TIME; STROOP TEST; TRAIL MAKING TEST;

EID: 84995685089     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyw054     Document Type: Article

References (24)

1. Basso MR, Bornstein RA (1999) Relative memory deficits in recurrent versus first-episode major depression on a word-list learning task. Neuropsychology 13:557-563.
2. Baune BT, Renger L (2014) Pharmacological and non-pharmacological interventions to improve cognitive dysfunction and functional ability in clinical depression-A systematic review. Psychiatry Res 219:25-50.
3. Biringer E, Rongve A, Lund A (2009) A review of modern antidepressants' effects on neurocognitive function. Curr Psychiatry Rev 5:164-174.
4. Conradi HJ, Ormel J, de Jonge P (2011) Presence of individual (residual) symptoms during depressive episodes and periods of remission: A 3-year prospective study. Psychol Med 41:1165-1174.
5. Dickinson D (2008) Digit symbol coding and general cognitive ability in schizophrenia: worth another look? Br J Psychiatry 193:354-356.
6. Donohue MC, Sperling RA, Salmon DP, Rentz DM, Raman R, Thomas RG, Weiner M, Aisen PS (2014) The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol 71:961-970.
7. Ferris SH, Lucca U, Mohs R (1997) Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord 11(3):34-8.
8. Hammar Å, Årdal G (2009) Cognitive functioning in major depression-A summary. Front Hum Neurosci 3:26. doi:10.3389/neuro.09.026.2009.
9. Harrison J, Henderson L, Kennard C (1995) Abnormal refractoriness in patients with Parkinson's disease after brief withdrawal of levodopa treatment. J Neurol Neurosurg Psychiatry 59:499-506.
10. Harrison JE (2016) Measuring the mind: detecting cognitive deficits and measuring cognitive change in patients with depression. In: Cognitive dysfunction in Major Depressive Disorder (McIntyre RS, Cha D, eds), pp. 229-241. Cambridge, UK: Cambridge University Press.
11. Hasselbalch BJ, Knorr U, Kessing LV (2011) Cognitive impairment in the remitted state of unipolar depressive disorder: A systematic review. J Affect Disord 134:20-31.
12. Katona C, Hansen T, Olsen CK (2012) A randomized, doubleblind, placebo-controlled, duloxetine-referenced, fixed-dose study comparing the efficacy and safety of Lu AA21004 in elderly patients with major depressive disorder. Int Clin Psychopharmacol 27:215-223.
13. Lee RS, Hermens DF, Porter MA, Redoblado-Hodge MA (2012) A meta-Analysis of cognitive deficits in first-episode Major Depressive Disorder. J Affect Disord 140:113-124.
14. Mahableshwarkar AR, Zajecka J, Jacobson W, Chen Y, Keefe RSE (2015) A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology 40:2025-2037.
15. McClintock SM, Husain MM, Greer TL, Cullum CM (2010) Association between depression severity and neurocognitive function in major depressive disorder: A review and synthesis. Neuropsychology 24:9-34.
16. McIntyre RS, Cha DS, Soczynska JK, Woldeyohannes HO, Gallaugher LA, Kudlow P, Alsuwaidan M, Baskaran A (2013) Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions. Depress Anxiety 30:515-527.
17. McIntyre RS, Lophaven S, Olsen CK (2014) A randomized, doubleblind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychop 17:1557- 1567.
18. Millan MJ, et al. (2012) Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov 11:141-168.
19. Papakostas GI (2014) Cognitive symptoms in patients with major depressive disorder and their implications for clinical practice. J Clin Psychiatry 75:8-14.
20. Porter RJ, Bourke C, Gallagher P (2007) Neuropsychological impairment in major depression: its nature, origin and clinical significance. Aus New Zeal J Psychiatry 41:115-128.
21. Rockwood K (2004) Size of the treatment effect on cognition of cholinesterase inhibition in Alzheimer's disease. J Neurol Neurosurg Psychiatry 75:677-685.
22. Trivedi MH, Greer TL (2014) Cognitive dysfunction in unipolar depression: implications for treatment. J Affect Disord 152-154:19-27.
23. Wechsler D (1997) Wechsler Adult Intelligence Scale, third ed. San Antonio, TX: Psychological Corporation.
24. Weisenbach SL, Boore LA, Kales HC (2012) Depression and cognitive impairment in older adults. Curr Psychiatry Rep 14:280-288.